US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder
Links shared publicly online about this topic.
- 1,553total visits
US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder
Astrazeneca (nyse: azn) announced that the us food and drug administration (fda) has approved once-daily seroquel xr® (quetiapine fumarate) extended release tablets as adjunctive (add-on) tre
View full resource at medicalnewstoday.com
Tags: Major Depression, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Drug, FDA, Seroquel, AstraZeneca
Most Recently Shared on December 5, 2009 at 12:19 pm By:
US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder: AstraZeneca (NYSE: AZN) annou.. http://bit.ly/7L8u0I
Advertisement
